Skip to main content

Table 3 Hazard ratios of gastrointestinal cancer in participants with/without hysterectomy from the Korea National Health Insurance Database, 2007–2020

From: The increased risk of colorectal cancer in the women who underwent hysterectomy from the South Korean National Health Insurance Database

 

Unadjusted

Adjusteda

HR (95% CI)a

P-value

HR (95% CI)a

p-value*

Esophageal cancer

 Reference (no hysterectomy)

1 (reference)

 

1 (reference)

 

 Hysterectomy alone

1.031 (0.337–3.156)

0.957

0.558 (0.104–3.001)

0.497

 Hysterectomy + adnexal surgery

0.726 (0.091–5.803)

0.763

0.355 (0.032–3.975)

0.401

Stomach cancer

 Reference (no hysterectomy)

1 (reference)

 

1 (reference)

 

 Hysterectomy alone

0.842 (0.679–1.045)

0.118

0.959 (0.689–1.334)

0.805

 Hysterectomy + adnexal surgery

0.781 (0.543–1.124)

0.183

0.854 (0.55–1.324)

0.48

Small bowel cancer

 Reference (no hysterectomy)

1 (reference)

 

1 (reference)

 

 Hysterectomy alone

1.069 (0.479–2.382)

0.871

0.724 (0.2–2.62)

0.622

 Hysterectomy + adnexal surgery

1 (0-Infinite)

0.984

1 (0-Infinite)

0.99

Colon cancer

 Reference (no hysterectomy)

1 (reference)

 

1 (reference)

 

 Hysterectomy alone

1.249 (0.996–1.566)

0.055

1.523 (1.068–2.17)

0.02

 Hysterectomy + adnexal surgery

0.999 (0.678–1.471)

0.994

1.138 (0.712–1.82)

0.589

Sigmoid cancer

 Reference (no hysterectomy)

1 (reference)

 

1 (reference)

 

 Hysterectomy alone

1.71 (1.073–2.724)

0.024

1.647 (0.808–3.359)

0.17

 Hysterectomy + adnexal surgery

1.168 (0.519–2.63)

0.708

1.045 (0.397–2.755)

0.929

Rectal cancer

 Reference (no hysterectomy)

1 (reference)

 

1 (reference)

 

 Hysterectomy alone

1.113 (0.808–1.531)

0.513

1.128 (0.7–1.818)

0.62

 Hysterectomy + adnexal surgery

1.924 (1.282–2.888)

0.002

1.933 (1.131–3.302)

0.016

Colorectal cancer

 Reference (no hysterectomy)

1 (reference)

 

1 (reference)

 

 Hysterectomy alone

1.222 (1.016–1.47)

0.033

1.406 (1.057–1.871)

0.019

 Hysterectomy + adnexal surgery

1.206 (0.902–1.613)

0.206

1.315 (0.917–1.884)

0.136

Gastrointestinal cancer

 Reference (no hysterectomy)

1 (reference)

 

1 (reference)

 

 Hysterectomy alone

1.029 (0.897–1.181)

0.68

1.169 (0.946–1.446)

0.149

 Hysterectomy + adnexal surgery

0.963 (0.768–1.206)

0.741

1.042 (0.791–1.372)

0.772

  1. CCI Charlson comorbidity index, CI confidence interval, HR hazard ratio, MHT menopausal hormone therapy, SES socioeconomic status
  2. *p-value less than 0.05 is statistically significant
  3. aHRs were adjusted for hysterectomy, age, SES, regrion, CCI, parity, menopause before inclusion, MHT before inclusion, adnexal surgery before inclusion, diseases of the gallbladder and biliary tract before inclusion, uterine leiomyoma, endometriosis